StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMMay 15, 2026, 01:17 PM

Grifols to Vote on 10% Capital Reduction, 50% Capital Increase, NASDAQ Listing

AI Summary

Grifols SA has called an Ordinary General Shareholders' Meeting for June 17 or 18, 2026, to address several key corporate matters. The agenda includes the approval of 2025 financial results, re-election of auditors and directors, and amendments to the directors' remuneration policy. Significantly, shareholders will vote on authorizing the Board to increase share capital by up to 50% and to reduce share capital by up to 10% through treasury share redemption. Additionally, the meeting will consider renewing the delegation for the listing of Class A shares on NASDAQ.

Key Highlights

  • Ordinary General Shareholders' Meeting scheduled for June 17, 2026 (first call) or June 18, 2026 (second call).
  • Shareholders to review and approve 2025 individual and consolidated annual accounts and management reports.
  • Proposal for re-election of Deloitte Auditores, S.L. as statutory auditor for fiscal years 2027, 2028, and 2029.
  • Re-election of Ms. Montserrat Muñoz Abellana and Ms. Susana González Rodríguez as Board members.
  • Amendment of the directors' remuneration policy and consultative vote on the Annual Remuneration Report.
  • Authorization for the Board to increase share capital up to 50% within five years, with power to exclude pre-emptive rights up to 20%.
  • Renewal of delegation to the Board to apply for the listing of Class A shares on NASDAQ.
  • Approval of a share capital reduction up to 10% by redeeming treasury Class A and Class B shares.